Research / BBWI / Fundamental state Inspectable configuration
State dimensions Filing 0000701985-26-000029 General Corporate
Debt relative to revenue 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
238.71% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.24% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.76% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-2.26% · CORE · VALID
Inventory pressure 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
58.32% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
45.71% · CORE · VALID
Operating margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.27% · CORE · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.13% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 51 states Self-history eligible
Oct 30, 2021 8/8 normalized Level 3 Jan 29, 2022 7/7 normalized Level 3 Apr 30, 2022 8/8 normalized Level 3 Jul 30, 2022 8/8 normalized Level 3 Oct 29, 2022 8/8 normalized Level 3 Jan 28, 2023 7/7 normalized Level 3 Apr 29, 2023 8/8 normalized Level 3 Jul 29, 2023 8/8 normalized Level 3 Oct 28, 2023 8/8 normalized Level 3 Feb 3, 2024 7/7 normalized Level 3 May 4, 2024 8/8 normalized Level 3 Aug 3, 2024 8/8 normalized Level 3 Nov 2, 2024 8/8 normalized Level 3 Feb 1, 2025 7/7 normalized Level 3 May 3, 2025 8/8 normalized Level 3 Aug 2, 2025 8/8 normalized Level 3 Nov 1, 2025 8/8 normalized Level 3 Jan 31, 2026 8/8 normalized Level 3 May 2, 2026 8/8 normalized Level 3 Aug 1, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 262.19%
Current 238.71%
Delta -23.49% Capex Intensity Decreased
Previous 3.56%
Current 3.24%
Delta -0.32% Cash Generation Decreased
Previous 17.71%
Current 4.76%
Delta -12.95% Growth Increased
Previous -3.23%
Current -2.26%
Delta 0.97% Inventory Pressure Increased
Previous 56.75%
Current 58.32%
Delta 1.57% Margin Increased
Previous 42.60%
Current 45.71%
Delta 3.11% Profitability Decreased
Previous 16.76%
Current 14.27%
Delta -2.50% Sbc Intensity Decreased
Previous 0.58%
Current 0.13%
Delta -0.45% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jan 31, 2026
Similarity 75%
Compared 8 dimensions
Coverage 100% Growth 25.0 · Margin 25.0 · Profitability 15.0 · Sbc Intensity 10.0 · Capex Intensity 10.0 · Cash Generation 35.0 · Inventory Pressure 40.0 · Balance Sheet Leverage 20.0 Feb 1, 2025
Similarity 73%
Compared 7 dimensions
Coverage 88% Growth 25.0 · Margin 15.0 · Profitability 20.0 · Sbc Intensity 45.0 · Capex Intensity 10.0 · Cash Generation 20.0 · Inventory Pressure 35.0 Jul 31, 2021
Similarity 73%
Compared 7 dimensions
Coverage 88% Growth 45.0 · Margin 10.0 · Profitability 45.0 · Sbc Intensity 15.0 · Capex Intensity 15.0 · Cash Generation 15.0 · Inventory Pressure 15.0 Jan 30, 2021
Similarity 72%
Compared 7 dimensions
Coverage 88% Growth 40.0 · Margin 10.0 · Profitability 30.0 · Sbc Intensity 10.0 · Capex Intensity 10.0 · Cash Generation 40.0 · Inventory Pressure 30.0 Jan 30, 2016
Similarity 71%
Compared 7 dimensions
Coverage 88% Margin 15.0 · Profitability 55.0 · Sbc Intensity 25.0 · Capex Intensity 2.5 · Cash Generation 12.5 · Inventory Pressure 42.5 · Balance Sheet Leverage 5.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.